MBKinéTherapy: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MBKinéTherapy
Largest movements
- Cash +€25,477
up €25,477 (+328%), from €7,767 to €33,244
mainly Net result for the year (+€17,111) and Receivables within one year (+€5,364)
- Receivables within one year -€5,364
down €5,364 (-59.2%), from €9,063 to €3,700
- Tangible fixed assets +€1,900
new in 2025: €1,900
- Profit (loss) carried forward +€17,111
up €17,111 (+236%), from €7,263 to €24,374
- Tax, wage and social debts +€3,931
up €3,931 (+166%), from €2,367 to €6,298
- Other debts +€1,497
up €1,497 (+50.4%), from €2,972 to €4,469
- Trade debts -€507
down €507 (-41.3%), from €1,228 to €721
- Gross operating margin +€24,541
up €24,541 (+270%), from €9,079 to €33,619
- Financial charges +€12,024
new in 2025: €12,024
- Taxes +€2,185
up €2,185 (+120%), from €1,816 to €4,001
- Depreciation +€484
new in 2025: €484
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €16,830 | €38,862 | +€22,032 | +131% |
| Fixed assets | 21/28 | - | €1,900 | +€1,900 | |
| Tangible fixed assets | 22/27 | - | €1,900 | +€1,900 | |
| Furniture and vehicles | 24 | - | €1,900 | +€1,900 | |
| Current assets | 29/58 | €16,830 | €36,962 | +€20,132 | +120% |
| Amounts receivable within one year | 40/41 | €9,063 | €3,700 | -€5,364 | -59.2% |
| Trade receivables | 40 | €9,063 | €3,700 | -€5,364 | -59.2% |
| Cash at bank and in hand | 54/58 | €7,767 | €33,244 | +€25,477 | +328% |
| Deferred charges and accrued income | 490/1 | - | €19 | +€19 | |
| Total equity and liabilities | 10/49 | €16,830 | €38,862 | +€22,032 | +131% |
| Equity | 10/15 | €10,263 | €27,374 | +€17,111 | +167% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €7,263 | €24,374 | +€17,111 | +236% |
| Amounts payable | 17/49 | €6,567 | €11,488 | +€4,921 | +74.9% |
| Amounts payable within one year | 42/48 | €6,567 | €11,488 | +€4,921 | +74.9% |
| Trade debts | 44 | €1,228 | €721 | -€507 | -41.3% |
| Suppliers | 440/4 | €1,228 | €721 | -€507 | -41.3% |
| Taxes, remuneration and social security | 45 | €2,367 | €6,298 | +€3,931 | +166% |
| Taxes | 450/3 | €2,367 | €6,298 | +€3,931 | +166% |
| Other amounts payable | 47/48 | €2,972 | €4,469 | +€1,497 | +50.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €484 | +€484 | |
| Gross operating margin | 9900 | €9,079 | €33,619 | +€24,541 | +270% |
| Operating profit (loss) | 9901 | €9,079 | €33,135 | +€24,056 | +265% |
| Financial charges | 65/66B | - | €12,024 | +€12,024 | |
| Recurring financial charges | 65 | - | €12,024 | +€12,024 | |
| Profit (loss) for the period before taxes | 9903 | €9,079 | €21,111 | +€12,033 | +133% |
| Income taxes | 67/77 | €1,816 | €4,001 | +€2,185 | +120% |
| Profit (loss) for the period | 9904 | €7,263 | €17,111 | +€9,848 | +136% |
| Profit (loss) for the period to be appropriated | 9905 | €7,263 | €17,111 | +€9,848 | +136% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.